Drug Shortage Report for CERUBIDINE
Report ID | 97019 |
Drug Identification Number | 01926683 |
Brand name | CERUBIDINE 20MG/VIAL |
Common or Proper name | CERUBIDINE |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | DAUNORUBICIN |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | VIAL |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-25 |
Actual start date | 2019-10-22 |
Estimated end date | 2019-12-27 |
Actual end date | 2019-12-21 |
Shortage status | Resolved |
Updated date | 2020-01-02 |
Company comments | AVAILABLE UNDER ALLOCATION |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-22 | English | Compare |
v2 | 2019-10-22 | French | Compare |
v3 | 2019-10-23 | English | Compare |
v4 | 2020-01-02 | English | Compare |
v5 | 2020-01-02 | French | Compare |
Showing 1 to 5 of 5